Estimating Utilities / Disutilities for High Risk Metastatic Hormone-Sensitive Prostate Cancer (MHSPC) and Treatment-Related Adverse Events
Abstract
Authors
F Hall HM de Freitas C Kerr T Ito B Nafees AJ Lloyd J Penton M Hadi T Pham